Eradication of methicillin-resistant Staphylococcus aureus infection by nanoliposomes loaded with gentamicin and oleic acid

Pharmaceutical Biology

Volumn 52, Issue 11, 2014, Pages 1423-1428

  Atashbeyk, Davod Ghoochi ^a   Khameneh, Bahman ^a   Tafaghodi, Mohsen ^b   Fazly Bazzaz, Bibi Sedigheh ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Combination therapy; Free fatty acid; Liposomes; Microbial resistance; Vancomycin

Indexed keywords

GENTAMICIN; LIPOSOME; NANOPARTICLE; OLEIC ACID; VANCOMYCIN; ANTIINFECTIVE AGENT; METICILLIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CLEARANCE; COMPARATIVE EFFECTIVENESS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG FORMULATION; DRUG POTENCY; DRUG SYNTHESIS; IN VITRO STUDY; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; ZETA POTENTIAL; DRUG COMBINATION; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; PHYSIOLOGY; PROCEDURES; STAPHYLOCOCCAL INFECTIONS;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; GENTAMICINS; LIPOSOMES; METHICILLIN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; NANOPARTICLES; OLEIC ACID; STAPHYLOCOCCAL INFECTIONS;

EID: 84912091341     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2014.895018     Document Type: Article

References (41)

1. Bababeygy SR, Silva RA, Sun Y, Jain A. (2009). Rifampin and linezolid in the treatment of methicillin-resistant Staphylococcus aureus preseptal cellulitis. Ophthal Plast Reconstr Surg 25:227-8.
2. Bakker-Woudenberg IAJM, Lokerse AF, Vink-Van den Berg JC, et al. (1986). Effect of liposome-entrapped ampicillin on survival of Listeria monocytogenes in murine peritoneal macrophages. Antimicrob Agents Chemother 30:295-300.
3. Balzli CL, McCormick CC, Caballero AR, et al. (2010). The effectiveness of an improved combination therapy for experimental Staphylococcus aureus keratitis. Adv Ther 27:933-40.
4. Barratt G. (2003). Colloidal drug carriers: Achievements and perspectives. Cell Mol Life Sci 60:21-37.
5. Barrett JF. (2005). MRSA-What is it, and how do we deal with the problem? Expert Opin Ther Targets 9:253-65
6. Bergsson G, Arnfinnsson J, Steingrímsson O, Thormar H. (2001). Killing of Gram-positive cocci by fatty acids and monoglycerides. APMIS 109:670-8.
7. Blecher K, Nasir A, Friedman A. (2011). The growing role of nanotechnology in combating infectious disease. Virulence 2: 395-401.
8. Bombelli C, Bordi F, Ferro S, et al. (2008). New cationic liposomes as vehicles of m-tetrahydroxyphenylchlorin in photodynamic therapy of infectious diseases. Mol Pharm 5:672-9.
9. Dangi A, Dwivedi V, Vedi S, et al. (2010). Improvement in the antifilarial efficacy of doxycycline and rifampicin by combination therapy and drug delivery approach. J Drug Target 18:343-50.
10. Desbois AP, Mearns-Spragg A, Smith VJ. (2009). A fatty acid from the diatom Phaeodactylum tricornutum is antibacterial against diverse bacteria including multi-resistant Staphylococcus aureus (MRSA). Mar Biotechnol 11:45-52.
11. Dezfulian A, Aslani MM, Oskoui M, et al. (2012). Identification and characterization of a high vancomycin-resistant Staphylococcus aureus harboring VanA gene cluster isolated from diabetic foot ulcer. Iran J Basic Med Sci 15:803-6.
12. Ferro S, Ricchelli F, Mancini G, et al. (2006). Inactivation of methicillin-resistant Staphylococcus aureus (MRSA) by liposome-delivered photosensitising agents. J Photochem Photobiol B 83:98-104.
13. Florescu I, Beuran M, Dimov R, et al. (2008). Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: A Phase 3, multicentre, double-blind, randomized study. J Antimicrob Chemother 62:i17-28.
14. Greenway DLA, Dyke KGH. (1979). Mechanism of the inhibitory action of linoleic acid on the growth of Staphylococcus aureus. J Gen Microbiol 115:233-45.
15. Griaznova NS, Beliavskaia IV, Afonin VI, et al. (1993). A comparative study of liposome-incorporated beta-lactam antibiotics, fluoroquino-lones and cephalosporin conjugates with fluoroquinolones. Antibiot Khimioter 38:3-6.
16. Heczko PB, Lutticken R, Hryniewicz W, et al. (1979). Susceptibility of Staphylococcus aureus and group A, B, C, and G streptococci to free fatty acids. J Clin Microbiol 9:333-5.
17. Huang CM, Chen CH, Pornpattananangkul D, et al. (2011). Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids. Biomaterials 32:214-21.
18. Kadry AA, Al-Suwayeh SA, Abd-Allah ARA, Bayomi MA. (2004). Treatment of experimental osteomyelitis by liposomal antibiotics. J Antimicrob Chemother 54:1103-8.
19. Kenny JG, Ward D, Josefsson E, et al. (2009). The Staphylococcus aureus response to unsaturated long chain free fatty acids: Survival mechanisms and virulence implications. PLoS One 4:e4344.
20. Khameneh B, Momen-nejad M, Tafaghodi M. (2014). In vivo evaluation of mucoadhesive properties of nanoliposomal formulations upon coating with trimethylchitosan polymer. Nanomed J 3:147-54.
21. Klevens R, Edwards JR, Andrus ML, et al. (2007). Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763-71.
22. Milatovic D. (1986). Vancomycin for treatment of infections with methicillin-resistant Staphylococcus aureus: Are there alternatives. Eur J Clin Microbiol Infect Dis 5:689-92.
23. Mugabe C, Halwani M, Azghani AO, et al. (2006). Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother 50:2016-22.
24. Nair MKM, Joy J, Vasudevan P, et al. (2005). Antibacterial effect of caprylic acid and monocaprylin on major bacterial mastitis pathogens. J Dairy Sci 88:3488-95.
25. National Committee for Clinical Laboratory Standards. (2000). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, Fifth ed. Approved Standard M7-A5. Wayne (PA): NCCLS.
26. Omri A, Ravaoarinoro M. (1996). Preparation, properties and the effects of amikacin, netilmicin and tobramycin in free and liposomal formulations on Gram-negative and Gram-positive bacteria. Int J Antimicrob Agents 7:9-14.
27. Pantosti A, Sanchini A, Monaco M. (2007). Mechanisms of antibiotic resistance in Staphylococcus aureus. Future Microbiol 2:323-34.
28. Pinto-Alphandary H, Andremont A, Couvreur P. (2000). Targeted delivery of antibiotics using liposomes and nanoparticles: Research and applications. Int J Antimicrob Agents 13:155-68.
29. Sande L, Sanchez M, Montes J, et al. (2012). Liposomal encapsulation of vancomycin improves killing of methicillin-resistant Staphylococcus aureus in a murine infection model. J Antimicrob Chemother 67: 2191-4.
30. Santos-Magalhães NS, Pontes A, Pereira VMW, Caetano MNP. (2000). Colloidal carriers for benzathine penicillin G: Nanoemulsions and nanocapsules. Int J Pharm 208:71-80.
31. Shibata H, Nakano T, Parvez MAK, et al. (2009). Triple combinations of lower and longer alkyl gallates and oxacillin improve antibiotic synergy against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 53:2218-20.
32. Speert DP, Wannamaker LW, Gray ED, Clawson CC. (1979). Bactericidal effect of oleic acid on group A streptococci: Mechanism of action. Infect Immun 26:1202-10.
33. Sun CQ, O'Connor CJ, Roberton AM. (2003). Antibacterial actions of fatty acids and monoglycerides against Helicobacter pylori. FEMS Immunol Med Microbiol 36:9-17.
34. Tafaghodi M, Jaafari M-R, Sajadi Tabassi SA. (2006). Nasal immunization studies using liposomes loaded with tetanus toxoid and CpG-ODN. Eur J Pharm Biopharm 64:138-45.
35. Tafaghodi M, Jaafari M, Sajadi Tabassi S. (2008). Nasal immunization studies by cationic, fusogenic and cationic-fusogenic liposomes encapsulated with tetanus toxoid. Curr Drug Deliv 5:108-13.
36. Timurkaynak F, Can F, Azap OK, et al. (2006). In vitro activities of non-traditional antimicrobials alone or in combination against multi-drug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Int J Antimicrob Agents 27:224-8.
37. Torres IMS, Bento EB, Almeida LC, et al. (2012). Preparation, characterization and in vitro antimicrobial activity of liposomal ceftazidime and cefepime against Pseudomonas aeruginosa strains. Braz J Microbiol 43:984-92.
38. Tsai T, Yang YT, Wang TH, et al. (2009). Improved photodynamic inactivation of Gram-positive bacteria using hematoporphyrin encapsulated in liposomes and micelles. Lasers Surg Med 41:316-22.
39. Turos E, Shim JY, Wang Y, et al. (2007). Antibiotic-conjugated polyacrylate nanoparticles: New opportunities for development of anti-MRSA agents. Bioorg Med Chem Lett 17:53-6.
40. Wallace SJ, Nation RL, Li J, Boyd BJ. (2013). Physicochemical aspects of the coformulation of colistin and azithromycin using liposomes for combination antibiotic therapies. J Pharm Sci 102: 1578-87.
41. Zadi B, Gregoriadis G. (2000). A novel method for high-yield entrapment of solutes into small liposomes. J Liposome Res 10:73-80.